Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 7Phase 3 5Phase 1 2

Status

Completed 2Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 73INDUSTRY 44NETWORK 5OTHER_GOV 2NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 97Genitourinary 90Other hematologic neoplasm 70Lymphoid 70Gastrointestinal 66Gynecologic 60CNS 48Sarcoma 46Thoracic 40Head & Neck 38Plasma cell 33Dermatologic 18Myeloid 15Other neoplasm 7Classical hematology 6Tumor-Agnostic 5Other solid neoplasm 4Other 4Endocrine 4

Conditions

Neoplasm Metastasis 3Carcinoma 2Adenocarcinoma 2Neoplasms, Unknown Primary 1Neoplasms 1

Interventions

regorafenib 2trifluridine tipiracil drug combination 1Trifluridine 1Radiotherapy 1Radiosurgery 1Psychiatric Rehabilitation 1Paclitaxel 1Nivolumab 1Music Therapy 1Irinotecan 1Docetaxel 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × NETWORK × Tumor-Agnostic × Clear all
NCT06391242 2026-03-27

Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases

Canadian Cancer Trials Group

Phase 3 Recruiting
230 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04879368 2025-07-17

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Active not recruiting
450 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT00305851 2022-07-15

Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant

Children's Oncology Group

Phase 3 Completed
118 enrolled
Tumor-Agnostic

Neoplasms

NCT02773524 2022-01-13

INTEGRATEIIa

Australasian Gastro-Intestinal Trials Group

Phase 3 Unknown
250 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT00047125 2018-07-09

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
600 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡